Towards next-generation personalization of tacrolimus treatment: A review on advanced diagnostic and therapeutic approaches

Arun Radhakrishnan, Gowthamarajan Kuppusamy, Sivasankaran Ponnusankar, Srinivas Mutalik

Research output: Contribution to journalReview articlepeer-review

Abstract

The benefit of personalized medicine is that it allows the customization of drug therapy - maximizing efficacy while avoiding side effects. Genetic polymorphisms are one of the major contributors to interindividual variability. Currently, the only gold standard for applying personalized medicine is dose titration. Because of technological advancements, converting genotypic data into an optimum dose has become easier than in earlier years. However, for many medications, determining a personalized dose may be difficult, leading to a trial-and-error method. On the other hand, the technologically oriented pharmaceutical industry has a plethora of smart drug delivery methods that are underutilized in customized medicine. This article elaborates the genetic polymorphisms of tacrolimus as case study, and extensively covers the diagnostic and therapeutic technologies which aid in the delivery of personalized tacrolimus treatment for better clinical outcomes, thereby providing a new strategy for implementing personalized medicine.

Original languageEnglish
Pages (from-to)1151-1175
Number of pages25
JournalPharmacogenomics
Volume22
Issue number17
DOIs
Publication statusPublished - 11-2021

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Genetics
  • Pharmacology

Fingerprint

Dive into the research topics of 'Towards next-generation personalization of tacrolimus treatment: A review on advanced diagnostic and therapeutic approaches'. Together they form a unique fingerprint.

Cite this